Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models
Authors
Keywords
Drug screen, Drug resistance, Preclinical model, Gene expression profiling, Cancer
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-04-07
DOI
10.1186/s12885-015-1237-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis
- (2015) Karen Dybkær et al. JOURNAL OF CLINICAL ONCOLOGY
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition
- (2014) Steffen Falgreen et al. BMC BIOINFORMATICS
- Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy
- (2014) Christian P. Pallasch et al. CELL
- Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
- (2014) Paul Geeleher et al. GENOME BIOLOGY
- Comparison and validation of genomic predictors for anticancer drug sensitivity
- (2013) Simon Papillon-Cavanagh et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Independent Validation of a Model Using Cell Line Chemosensitivity to Predict Response to Therapy
- (2013) Wenting Wang et al. JNCI-Journal of the National Cancer Institute
- Inconsistency in large pharmacogenomic studies
- (2013) Benjamin Haibe-Kains et al. NATURE
- Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
- (2013) Paul Blanche et al. STATISTICS IN MEDICINE
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial
- (2012) Kui Shen et al. BMC Medical Genomics
- Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma
- (2012) Stefano Monti et al. CANCER CELL
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) C Visco et al. LEUKEMIA
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Comparing Statistical Methods for Quantifying Drug Sensitivity Based on In Vitro Dose–Response Assays
- (2011) Shuguang Huang et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- New Strategies in Diffuse Large B-cell Lymphoma: Translating Findings from Gene Expression Analyses into Clinical Practice
- (2011) J. W. Friedberg CLINICAL CANCER RESEARCH
- A 71-Gene Signature of TRAIL Sensitivity in Cancer Cells
- (2011) J.-J. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Generation of a Predictive Melphalan Resistance Index by Drug Screen of B-Cell Cancer Cell Lines
- (2011) Martin Boegsted et al. PLoS One
- To Explain or to Predict?
- (2011) Galit Shmueli STATISTICAL SCIENCE
- Deriving chemosensitivity from cell lines: Forensic bioinformatics and reproducible research in high-throughput biology
- (2010) Keith A. Baggerly et al. Annals of Applied Statistics
- Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2010) J. K. Lee et al. CLINICAL CANCER RESEARCH
- Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era
- (2010) Marita Ziepert et al. JOURNAL OF CLINICAL ONCOLOGY
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
- (2010) NATURE BIOTECHNOLOGY
- Aggressive Lymphomas
- (2010) Georg Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Independent filtering increases detection power for high-throughput experiments
- (2010) R. Bourgon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines
- (2009) Cornelia Liedtke et al. BREAST CANCER RESEARCH AND TREATMENT
- Concordant Gene Expression Signatures Predict Clinical Outcomes of Cancer Patients Undergoing Systemic Therapy
- (2009) P. D. Williams et al. CANCER RESEARCH
- The F Box Protein Fbx6 Regulates Chk1 Stability and Cellular Sensitivity to Replication Stress
- (2009) You-Wei Zhang et al. MOLECULAR CELL
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Damage Response Pathways in Tumor Suppression and Cancer Treatment
- (2008) Yulong Liang et al. WORLD JOURNAL OF SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started